Week in review October 18th 2025

Biotech Breakthroughs: Partnerships, AI, and Clinical Triumphs

Pharma Breakthroughs: Advancing Cancer, Diabetes, and HIV Care

Navigating Regulatory Shifts and Strategic Mergers in Biotech

Revolutionizing Care: Key Biotech Breakthroughs and Trends

Pharma and Biotech Daily: Keeping You Informed on FDA Approvals, Breakthroughs, and More

Week in Review - October 10, 2025

Pharma and Biotech Daily: Novo's Acquisition, FDA Breakthroughs, and Industry Updates

Pharma and Biotech Daily: Top Stories in the Industry from Zenas to Lilly

Pharma and Biotech Daily: Tariff Impact, Promising Trials, and Industry Leaders

Pharma and Biotech Daily: The Latest in Cell and Gene Therapy, M&A Activity, and Regulatory Updates

The Essential Updates in Pharma and Biotech: Your Daily Dose of What Matters

Pharma and Biotech Daily: Top Stories from the Industry

Pharma and Biotech Daily: Navigating Industry Shifts and Emerging Trends

Pharma and Biotech Daily: Metsera's Mid-Stage Success, AI in Drug Production, and GSK's CEO Resignation

Pharma and Biotech Daily: Genmab Acquires Merus, GSK CEO Steps Down, FDA Transparency Concerns, and More!

Pharma and Biotech Daily: Trump's Tariff Deadline, FDA Approvals, and Price-Lowering Efforts

Promising Results for Atebimetinib in Pancreatic Cancer & Other Pharma Updates

The Rise and Challenges of Chinese Biotech: A Global Powerhouse Facing Financial Hurdles

Pharma and Biotech Daily: FDA Revives Drug for Autism, Tylenol Pregnancy Warning, and More!